Market Reports /
by Melissa Darmawan -
A year ago
21 Jun 2022 - Australian shares snapped a 7-day losing streak led by resource and financial stocks amid the US futures pointing to a rise as Wall Street looks to resume trade after…
Market Reports /
by Melissa Darmawan -
A year ago
21 Jun 2022 - The ASX is set to snap a 7-day losing streak as investors were relieved that RBA governor Philip Lowe doesn’t see a local recession coming.
Market Reports /
by Melissa Darmawan -
3 years ago
15 Apr 2021 - The ASX continued its winning streak for the third day, setting a new 13-month high. Materials and energy shares were among the few bright spots on the market, with t…
Company News /
by Melissa Darmawan -
3 years ago
15 Apr 2021 - Recce Pharmaceticals’ (ASX:RCE) lead compound RECCE® 327 has been registered in the Australian New Zealand Clinical Trial Registry (ANZCTR) for its Phase I/II Topical…
Company News /
by Michael Luu -
3 years ago
Apr 2021 - Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illnes…
Company Presentations /
by -
3 years ago
31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) Managing Director & CEO, James Graham provides an update on its portfolio of Synthetic Anti-Infectives to address the…
Interviews /
by Rachael Jones -
3 years ago
31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 32…
Market Reports /
by Rachael Jones -
3 years ago
16 Mar 2021 - Following positive leads from US markets due to a tech push, the ASX looks set to open higher. Germany, France, Spain, Italy, Ireland and the Netherlands have joined …
Company News /
by Rachael Jones -
3 years ago
26 Nov 2020 - Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million of Synthetic Antibiotic Research & Development applicable expenditure by AusIndustry.
Market Reports /
by Rachael Jones -
3 years ago
30 Sep 2020 - The ASX failed to gain momentum today closing 2.3 % lower. Wall Street futures plummeted quickly at the conclusion of the US presidential debate earlier today. Marred…
Company News /
by Rachael Jones -
3 years ago
30 Sep 2020 - Recce Pharmaceuticals (ASX:RCE) has entered into an agreement with the Murdoch Children’s Research Institute to conduct pre-clinical studies assessing the potential o…
Interviews /
by Katrina Bullock -
3 years ago
15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's…
Company Presentations /
by -
4 years ago
19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham presents on the company's lead product RECCE 327, including significant progress with manufac…
Interviews /
by Anna Napoli -
4 years ago
19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manuf…
Market Reports /
by Rachael Jones -
4 years ago
30 Aug 2019 - The ASX opened higher and continued to rise throughout the morning now tracking at 1.2% higher at noon. The market has been bolstered by the Information Technology se…
Interviews /
by Jessica Amir -
4 years ago
03 Jun 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including significant progress wi…
Market Reports /
by Jessica Amir -
5 years ago
14 Mar 2019 - ASX snaps 4-day downward trend on Wall Street hitting fresh highs. Zip Co (ASX:Z1P) raises $42.8 million to bolster growth, Megaport (ASX:MP1) raises $50 million to …
Company News /
by Katrina Bullock -
5 years ago
08 Feb 2019 - Recce Pharmaceuticals (ASX:RCE) has raised $1.8 million via a placement from sophisticated and institutional investors.
Interviews /
by Jessica Amir -
5 years ago
30 Nov 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's RECCE 327 product in targeting antibiotic-resistant bacte…
Company Presentations /
by -
5 years ago
30 Nov 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's RECCE 327 product for use in targeting antibiotic resista…
Company Presentations /
by -
5 years ago
14 Jun 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham presents on the company's lead product RECCE 327 for use in targeting antibiotic-resistant ba…
Interviews /
by Anna Napoli -
5 years ago
14 Jun 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham talks about the company's lead product RECCE 327 for use in targeting antibiotic-resistant ba…
